Revolutionizing at‐home testing of blood‐based <i>p</i> ‐tau217 for early detection of Alzheimer's disease: A validation study of the Tasso Lancet Device
This study aims to validate a novel, non-invasive at-home sampling method for p-tau217, facilitating early AD detection and more frequent testing. By improving accessibility, this approach could enhance clinical practice and research, making early diagnosis feasible for a broader population.
Authors
- Elisabeth H. Thijssen (ORCID: https://orcid.org/0000-0002-9723-5441)
Institutions
- Center For Biomarker Research In Medicine (AT)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_102264
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00